1. Home
  2. ABM vs BEAM Comparison

ABM vs BEAM Comparison

Compare ABM & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ABM Industries Incorporated

ABM

ABM Industries Incorporated

N/A

Current Price

$47.58

Market Cap

2.6B

Sector

Finance

ML Signal

N/A

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

N/A

Current Price

$26.31

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ABM
BEAM
Founded
1909
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ABM
BEAM
Price
$47.58
$26.31
Analyst Decision
Buy
Buy
Analyst Count
4
14
Target Price
$51.50
$46.00
AVG Volume (30 Days)
677.8K
2.1M
Earning Date
03-11-2026
02-24-2026
Dividend Yield
2.46%
N/A
EPS Growth
102.34
N/A
EPS
2.59
N/A
Revenue
$8,745,900,000.00
$55,701,000.00
Revenue This Year
$5.71
N/A
Revenue Next Year
$1.99
$22.06
P/E Ratio
$18.19
N/A
Revenue Growth
4.62
N/A
52 Week Low
$40.00
$13.53
52 Week High
$54.90
$36.44

Technical Indicators

Market Signals
Indicator
ABM
BEAM
Relative Strength Index (RSI) 64.63 41.22
Support Level $45.25 $24.30
Resistance Level $46.60 $29.26
Average True Range (ATR) 0.95 2.12
MACD 0.17 -0.80
Stochastic Oscillator 100.00 15.40

Price Performance

Historical Comparison
ABM
BEAM

About ABM ABM Industries Incorporated

ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: